Devyser secures a major SEK 16.8M tender in Italy with 30% growth
Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Devyser Thalassemia achieves 99.9% sensitivity: Insights from a recent study
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
